G. Partesotti

Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry.

F. Angrilli, L. Cavanna, M. Federico, 2000, Haematologica.

The length of treatment of aggressive non‐Hodgkin's lymphomas established according to the international prognostic index score: long‐term results of the GISL LA03 study

P. Gobbi, S. Sacchi, M. Federico, 2006, European journal of haematology.

Paraneoplastic endocrine-metabolic syndromes

E. Romagnani, C. Benatti, M. Grandi, 2013 .

Le sindromi paraneoplastiche endocrino-metaboliche Paraneoplastic endocrine-metabolic syndromes

E. Romagnani, C. Benatti, M. Grandi, 2009 .

Immunoglobulin mutational status detected through single-round amplification of partial V(H) region represents a good prognostic marker for clinical outcome in chronic lymphocytic leukemia.

R. Marasca, M. Morselli, G. Torelli, 2005, The Journal of molecular diagnostics : JMD.

Incidence, clinical characteristics and survival of malignant lymphomas: a population‐based study from a cancer registry in northern Italy

M. Federico, I. Rashid, A. Maiorana, 2007, Hematological oncology.

MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavorably presenting Hodgkin's disease: a report from the Italian Lymphoma Study Group.

P. Gobbi, L. Cavanna, E. Iannitto, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

EARLY STAGE Follicular Lymphoma: First Results of the FIL "Miro" Study, a Multicenter Phase II Trial Combining Local Radiotherapy and MRD-Driven Immunotherapy

R. Foà, A. Guarini, S. Ferrero, 2019, Blood.